These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 24361600)

  • 1. Prodegenerative IκBα expression in oligodendroglial α-synuclein models of multiple system atrophy.
    Kragh CL; Gysbers AM; Rockenstein E; Murphy K; Halliday GM; Masliah E; Jensen PH
    Neurobiol Dis; 2014 Mar; 63():171-83. PubMed ID: 24361600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous oligodendroglial alpha-synuclein and TPPP/p25α orchestrate alpha-synuclein pathology in experimental multiple system atrophy models.
    Mavroeidi P; Arvanitaki F; Karakitsou AK; Vetsi M; Kloukina I; Zweckstetter M; Giller K; Becker S; Sorrentino ZA; Giasson BI; Jensen PH; Stefanis L; Xilouri M
    Acta Neuropathol; 2019 Sep; 138(3):415-441. PubMed ID: 31011860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAS-dependent cell death in α-synuclein transgenic oligodendrocyte models of multiple system atrophy.
    Kragh CL; Fillon G; Gysbers A; Hansen HD; Neumann M; Richter-Landsberg C; Haass C; Zalc B; Lubetzki C; Gai WP; Halliday GM; Kahle PJ; Jensen PH
    PLoS One; 2013; 8(1):e55243. PubMed ID: 23372841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy.
    Bassil F; Guerin PA; Dutheil N; Li Q; Klugmann M; Meissner WG; Bezard E; Fernagut PO
    Mov Disord; 2017 Aug; 32(8):1230-1239. PubMed ID: 28556404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy.
    Song YJ; Lundvig DM; Huang Y; Gai WP; Blumbergs PC; Højrup P; Otzen D; Halliday GM; Jensen PH
    Am J Pathol; 2007 Oct; 171(4):1291-303. PubMed ID: 17823288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential.
    Ferreira N; Gram H; Sorrentino ZA; Gregersen E; Schmidt SI; Reimer L; Betzer C; Perez-Gozalbo C; Beltoja M; Nagaraj M; Wang J; Nowak JS; Dong M; Willén K; Cholak E; Bjerregaard-Andersen K; Mendez N; Rabadia P; Shahnawaz M; Soto C; Otzen DE; Akbey Ü; Meyer M; Giasson BI; Romero-Ramos M; Jensen PH
    Acta Neuropathol; 2021 Jul; 142(1):87-115. PubMed ID: 33978813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapidly progressive multiple system atrophy-cerebellar variant model presenting marked glial reactions with inflammation and spreading of α-synuclein oligomers and phosphorylated α-synuclein aggregates.
    Yamaguchi H; Nishimura Y; Matsuse D; Sekiya H; Masaki K; Tanaka T; Saiga T; Harada M; Kira YI; Dickson DW; Fujishima K; Matsuo E; Tanaka KF; Yamasaki R; Isobe N; Kira JI
    Brain Behav Immun; 2024 Oct; 121():122-141. PubMed ID: 38986725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCAS1-positive immature oligodendrocytes are affected by the α-synuclein-induced pathology of multiple system atrophy.
    Kaji S; Maki T; Ueda J; Ishimoto T; Inoue Y; Yasuda K; Sawamura M; Hikawa R; Ayaki T; Yamakado H; Takahashi R
    Acta Neuropathol Commun; 2020 Jul; 8(1):120. PubMed ID: 32727582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy.
    Ettle B; Kerman BE; Valera E; Gillmann C; Schlachetzki JC; Reiprich S; Büttner C; Ekici AB; Reis A; Wegner M; Bäuerle T; Riemenschneider MJ; Masliah E; Gage FH; Winkler J
    Acta Neuropathol; 2016 Jul; 132(1):59-75. PubMed ID: 27059609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies.
    Refolo V; Bez F; Polissidis A; Kuzdas-Wood D; Sturm E; Kamaratou M; Poewe W; Stefanis L; Angela Cenci M; Romero-Ramos M; Wenning GK; Stefanova N
    Acta Neuropathol Commun; 2018 Jan; 6(1):2. PubMed ID: 29298733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathology of Multiple System Atrophy, a Glioneuronal Degenerative Disease.
    Wakabayashi K; Miki Y; Tanji K; Mori F
    Cerebellum; 2024 Feb; 23(1):2-12. PubMed ID: 35474048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased neuronal α-synuclein pathology associates with its accumulation in oligodendrocytes in mice modeling α-synucleinopathies.
    Kisos H; Pukaß K; Ben-Hur T; Richter-Landsberg C; Sharon R
    PLoS One; 2012; 7(10):e46817. PubMed ID: 23077527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.
    Shults CW; Rockenstein E; Crews L; Adame A; Mante M; Larrea G; Hashimoto M; Song D; Iwatsubo T; Tsuboi K; Masliah E
    J Neurosci; 2005 Nov; 25(46):10689-99. PubMed ID: 16291942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SNCA and TPPP transcripts increase in oligodendroglial cytoplasmic inclusions in multiple system atrophy.
    Kon T; Forrest SL; Lee S; Li J; Chasiotis H; Nassir N; Uddin MJ; Lang AE; Kovacs GG
    Neurobiol Dis; 2024 Aug; 198():106551. PubMed ID: 38839023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of α-Synuclein by Oligodendrocytes in Transgenic Mice Does Not Recapitulate the Fibrillar Aggregation Seen in Multiple System Atrophy.
    Laferrière F; He X; Zinghirino F; Doudnikoff E; Faggiani E; Meissner WG; Bezard E; De Giorgi F; Ichas F
    Cells; 2020 Oct; 9(11):. PubMed ID: 33138150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolyl oligopeptidase inhibition reduces alpha-synuclein aggregation in a cellular model of multiple system atrophy.
    Cui H; Kilpeläinen T; Zouzoula L; Auno S; Trontti K; Kurvonen S; Norrbacka S; Hovatta I; Jensen PH; Myöhänen TT
    J Cell Mol Med; 2021 Oct; 25(20):9634-9646. PubMed ID: 34486218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple system atrophy: a primary oligodendrogliopathy.
    Wenning GK; Stefanova N; Jellinger KA; Poewe W; Schlossmacher MG
    Ann Neurol; 2008 Sep; 64(3):239-46. PubMed ID: 18825660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates.
    Mandel RJ; Marmion DJ; Kirik D; Chu Y; Heindel C; McCown T; Gray SJ; Kordower JH
    Acta Neuropathol Commun; 2017 Jun; 5(1):47. PubMed ID: 28619074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal to oligodendroglial α-synuclein redistribution in a double transgenic model of multiple system atrophy.
    Rockenstein E; Ubhi K; Inglis C; Mante M; Patrick C; Adame A; Masliah E
    Neuroreport; 2012 Mar; 23(4):259-64. PubMed ID: 22314685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors.
    Ubhi K; Rockenstein E; Mante M; Inglis C; Adame A; Patrick C; Whitney K; Masliah E
    J Neurosci; 2010 May; 30(18):6236-46. PubMed ID: 20445049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.